Janus Henderson Group
AGL icon

Janus Henderson Group’s Agilon Health AGL Stock Holding History

Janus Henderson Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,490
Closed -$141K – 2406
2025
Q3 		$141K Hold
5,490
– – ﹤0.01% 2375
2025
Q2 		$314K Hold
5,490
– – ﹤0.01% 2148
2025
Q1 		$616K Hold
5,490
– – ﹤0.01% 1852
2024
Q4 		$260K Hold
5,490
– – ﹤0.01% 2316
2024
Q3 		$537K Hold
5,490
– – ﹤0.01% 2002
2024
Q2 		$898K Sell
5,490
-62
-1% -$8.83K ﹤0.01% 1676
2024
Q1 		$846K Buy
5,552
+19
+0.3% +$3.16K ﹤0.01% 1733
2023
Q4 		$1.74M Sell
5,533
-7
-0.1% -$2.53K ﹤0.01% 1328
2023
Q3 		$2.46M Sell
5,540
-1
-0% -$452 ﹤0.01% 1077
2023
Q2 		$2.4M Buy
5,541
+1,720
+45% +$967K ﹤0.01% 1153
2023
Q1 		$2.27M Buy
3,821
+2,239
+142% +$1.25M ﹤0.01% 1190
2022
Q4 		$638K Sell
1,582
-1,582
-50% -$742K ﹤0.01% 1579
2022
Q3 		$1.85M Buy
3,164
+1,536
+94% +$920K ﹤0.01% 1339
2022
Q2 		$892K Buy
+1,628
New +$823K ﹤0.01% 1401
2022
Q1 		– Sell
-43,151
Closed -$29.1M – 2644
2021
Q4 		$29.1M Sell
43,151
-553
-1% -$336K 0.01% 697
2021
Q3 		$28.6M Sell
43,704
-10,565
-19% -$9.02M 0.01% 704
2021
Q2 		$55M Buy
+54,269
New +$47.5M 0.02% 544

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Janus Henderson Group's AGL Position: Q4 2025 in Review

Janus Henderson Group sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 5,490 shares — an estimated $141K sold.

Janus Henderson Group first reported a position in AGL in Q2 2021 and held it in 17 quarters. The position peaked at $55M in Q2 2021. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Janus Henderson Group reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Janus Henderson Group sold 5,490 Agilon Health shares in Q4 2025, an estimated $141K.
  • Janus Henderson Group first reported a position in Agilon Health in Q2 2021 and held it in 17 quarters.
  • Janus Henderson Group's Agilon Health position peaked at $55M in Q2 2021.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.